‘Pharmacy platform company’ Baropharm newly listed on KOSDAQ… Trading from the 11th
Quick Look
The Korea Exchange approved the new listing on KOSDAQ of Baropharm, a pharmacy integrated platform operator established in 2019, and the first transaction will begin on the 11th.
AI-generated summary
Why It Matters
Baropharm is a pharmacy integrated platform operator established in 2019.
(Seoul = Yonhap News) Reporter Yuhyang Kim = The Korea Exchange announced on the 9th that it approved Baropharm's new listing on the KOSDAQ market.
The first transaction will take place on the 11th.
Founded in 2019, Baropharm is an information service company that operates an integrated pharmacy platform.
Last year, on a consolidated basis, it recorded sales of 96.724 billion won and an operating loss of 3.932 billion won.
The public offering price was 164 million won, and Mirae Asset Securities hosted the listing.
What to Watch
AI outlook — possibilities, not facts
Baropharm KOSDAQ market first trading begins
Very likely · Within days
Open Questions
- Stock price trend after listing
- Operating loss improvement plan







